STAT3 and lung carcinoma: Several reports have revealed that STAT3 is involved in IL-17-induced VEGF production in malignant tumours18, 19, 20, including lung cancer15, and one study7 has demonstrated that IL-17 influences IL-6, IL-8 and VEGF expression in lung cancer cell lines via an unknown mechanism.